Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2016

Open Access 01-08-2016 | Research Article

Quality indicators for pharmaceutical care: a comprehensive set with national scores for Dutch community pharmacies

Authors: Martina Teichert, Tim Schoenmakers, Nico Kylstra, Berend Mosk, Marcel L. Bouvy, Frans van de Vaart, Peter A. G. M. De Smet, Michel Wensing

Published in: International Journal of Clinical Pharmacy | Issue 4/2016

Login to get access

Abstract

Background The quality of pharmaceutical care in community pharmacies in the Netherlands has been assessed annually since 2008. The initial set has been further developed with pharmacists and patient organizations, the healthcare inspectorate, the government and health insurance companies. The set over 2012 was the first set of quality indicators for community pharmacies which was validated and supported by all major stakeholders. The aims of this study were to describe the validated set of quality indicators for community pharmacies and to report their scores over 2012. In subanalyses the score development over 5 years was described for those indicators, that have been surveyed before and remained unchanged. Methods Community pharmacists in the Netherlands were invited in 2013 to provide information for the set of 2012. Quality indicators were mapped by categories relevant for pharmaceutical care and defined for structures, processes and dispensing outcomes. Scores for categorically-measured quality indicators were presented as the percentage of pharmacies reporting the presence of a quality aspect. For numerical quality indicators, the mean of all reported scores was expressed. In subanalyses for those indicators that had been questioned previously, scores were collected from earlier measurements for pharmacies providing their scores in 2012. Multilevel analysis was used to assess the consistency of scores within one pharmacy over time by the intra-class correlation coefficient (ICC). Results For the set in 2012, 1739 Dutch community pharmacies (88 % of the total) provided information for 66 quality indicators in 10 categories. Indicator scores on the presence of quality structures showed relatively high quality levels. Scores for processes and dispensing outcomes were lower. Subanalyses showed that overall indicators scores improved within pharmacies, but this development differed between pharmacies. Conclusions A set of validated quality indicators provided insight into the quality of pharmaceutical care in the Netherlands. The quality of pharmaceutical care improved over time. As of 2012 quality structures were present in at least 80 % of the community pharmacies. Variation in scores on care processes and outcomes between individual pharmacies and over time can initiate future research to better understand and facilitate quality improvement in community pharmacies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Campbell SM, Braspenning J, Hutchinson A, Marshall M. Research methods used in developing and applying qyality indicators in primary care. BMJ. 2003;2226(326):816–19.CrossRef Campbell SM, Braspenning J, Hutchinson A, Marshall M. Research methods used in developing and applying qyality indicators in primary care. BMJ. 2003;2226(326):816–19.CrossRef
3.
go back to reference Campbell S, Kontopantelis E, Hannon K, et al. Framework and indicator testing protocol for developing and piloting quality indicators for the UK quality and outcomes framework. BMC Fam Pract. 2011;12(85):85–96.CrossRefPubMedPubMedCentral Campbell S, Kontopantelis E, Hannon K, et al. Framework and indicator testing protocol for developing and piloting quality indicators for the UK quality and outcomes framework. BMC Fam Pract. 2011;12(85):85–96.CrossRefPubMedPubMedCentral
5.
go back to reference Szecsenyi J, Broge B, Eckhardt J, Heller G, Kaufmann-Kolle P, Wensing M. Tearing down walls: opening the border between hospital and ambulatory care for quality improvement in Germany. Int J Qual Health Care. 2012;24(2):101–4. Szecsenyi J, Broge B, Eckhardt J, Heller G, Kaufmann-Kolle P, Wensing M. Tearing down walls: opening the border between hospital and ambulatory care for quality improvement in Germany. Int J Qual Health Care. 2012;24(2):101–4.
6.
go back to reference Romano P, Mull H, Rivard P, et al. Validity of selected AHRQ patient safety indicators based on VA National Surgical Quality Improvement Program data. Health Serv Res. 2009;44:182–204.CrossRefPubMedPubMedCentral Romano P, Mull H, Rivard P, et al. Validity of selected AHRQ patient safety indicators based on VA National Surgical Quality Improvement Program data. Health Serv Res. 2009;44:182–204.CrossRefPubMedPubMedCentral
7.
go back to reference van Doorn-Klomberg A, Braspenning J, Wolters R, Bouma M. M. W. Effect of accreditation on the quality of chronic disease management: a comparative observational study. BMC Fam Pract. 2014;4(15):179.CrossRef van Doorn-Klomberg A, Braspenning J, Wolters R, Bouma M. M. W. Effect of accreditation on the quality of chronic disease management: a comparative observational study. BMC Fam Pract. 2014;4(15):179.CrossRef
8.
go back to reference Elwyn G, Bekkers M-J, Tapp L, Edwards A, Newcombe R, Eriksson T, et al. Facilitating organisational development using a group-based formative assessment and benchmarking method: design and implementation of the International Family Practice Maturity Matrix. Qual Saf Health Care. 2010;19(6):e48. doi:10.1136/qshc.2009.037580. Elwyn G, Bekkers M-J, Tapp L, Edwards A, Newcombe R, Eriksson T, et al. Facilitating organisational development using a group-based formative assessment and benchmarking method: design and implementation of the International Family Practice Maturity Matrix. Qual Saf Health Care. 2010;19(6):e48. doi:10.​1136/​qshc.​2009.​037580.
10.
go back to reference De Bie J, Kijlstra N, Daemen B, Bouvy M. The development of quality indicators for community pharmacy care. BMJ Qual Saf. 2011;20(8):666–71.CrossRefPubMed De Bie J, Kijlstra N, Daemen B, Bouvy M. The development of quality indicators for community pharmacy care. BMJ Qual Saf. 2011;20(8):666–71.CrossRefPubMed
11.
go back to reference Schoenmakers T, Teichert M, Braspenning J, Vunderink L, de Smet P, Wensing M. Evaluation of quality indiators for Dutch community pharmacies using a comprehensive assessment framework. J Manag Care Pharm. 2015;21(2):144–52. Schoenmakers T, Teichert M, Braspenning J, Vunderink L, de Smet P, Wensing M. Evaluation of quality indiators for Dutch community pharmacies using a comprehensive assessment framework. J Manag Care Pharm. 2015;21(2):144–52.
13.
go back to reference Buurma H, Bouvy ML, De Smet PAGM, Floor-Schreudering A, Leufkens HGM, Egberts ACG. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008;33(1):17–23.CrossRefPubMed Buurma H, Bouvy ML, De Smet PAGM, Floor-Schreudering A, Leufkens HGM, Egberts ACG. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008;33(1):17–23.CrossRefPubMed
18.
go back to reference Twisk J. Applied multilevel analysis. Cambridge University Press; 2006. p. 46. ISBN 0-521-61498-8:14. Twisk J. Applied multilevel analysis. Cambridge University Press; 2006. p. 46. ISBN 0-521-61498-8:14.
19.
go back to reference Hermanides HS, Hulscher MEJL, Schouten JA, Prins JM, Geerlings SE. Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care. Clin Infect Dis. 2008;46:703–11.CrossRefPubMed Hermanides HS, Hulscher MEJL, Schouten JA, Prins JM, Geerlings SE. Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care. Clin Infect Dis. 2008;46:703–11.CrossRefPubMed
21.
go back to reference Morris C, Cantrill J, Hepler C, Noyce P. Preventing drug-related morbidity–determining valid indicators. Int J Qual Health Care. 2002;14(3):183–98.CrossRefPubMed Morris C, Cantrill J, Hepler C, Noyce P. Preventing drug-related morbidity–determining valid indicators. Int J Qual Health Care. 2002;14(3):183–98.CrossRefPubMed
22.
go back to reference Morris C, Cantrill J. Preventing drug-related morbidity–the development of quality indicators. J Clin Pharm Ther. 2003;28(4):295–305.CrossRefPubMed Morris C, Cantrill J. Preventing drug-related morbidity–the development of quality indicators. J Clin Pharm Ther. 2003;28(4):295–305.CrossRefPubMed
23.
go back to reference To T, Guttmann A, Lougheed M, Gershon A, Dell S, Stanbrook M, et al. Evidence-based performance indicators of primary care for asthma: a modified RAND Appropriateness Method. Int J Qual Health Care. 2010;22(6):476–85.CrossRefPubMed To T, Guttmann A, Lougheed M, Gershon A, Dell S, Stanbrook M, et al. Evidence-based performance indicators of primary care for asthma: a modified RAND Appropriateness Method. Int J Qual Health Care. 2010;22(6):476–85.CrossRefPubMed
24.
go back to reference Uphoff E, Wennekes L, Punt C, Grol R, Wollersheim H, Hermens R, et al. Development of generic quality indicators for patient-centered cancer care by using a RAND modified Delphi method. Cancer Nurs. 2012;35(1):29–37.CrossRefPubMed Uphoff E, Wennekes L, Punt C, Grol R, Wollersheim H, Hermens R, et al. Development of generic quality indicators for patient-centered cancer care by using a RAND modified Delphi method. Cancer Nurs. 2012;35(1):29–37.CrossRefPubMed
25.
go back to reference Caughey GE, Ellett LMK, Wong TY. Development of evidence-based Australian medication-related indicators of potentially preventable hospitalisations: a modified RAND appropriateness method. BMJ. 2014;4:e004625. doi:10.1136/bmjopen-2013-004625.CrossRef Caughey GE, Ellett LMK, Wong TY. Development of evidence-based Australian medication-related indicators of potentially preventable hospitalisations: a modified RAND appropriateness method. BMJ. 2014;4:e004625. doi:10.​1136/​bmjopen-2013-004625.CrossRef
26.
go back to reference Martirosyan L, Braspenning J, Denig P, de Grauw W, Bouma M, Storms F, et al. Prescribing quality indicators of type 2 diabetes mellitus ambulatory care. Qual Saf Health Care. 2008;17(5):318–23.CrossRefPubMed Martirosyan L, Braspenning J, Denig P, de Grauw W, Bouma M, Storms F, et al. Prescribing quality indicators of type 2 diabetes mellitus ambulatory care. Qual Saf Health Care. 2008;17(5):318–23.CrossRefPubMed
27.
go back to reference Yoon D, Park I, Schuemie M, Park M, Kim J, Park R. A quantitative method for assessment of prescribing patterns using electronic health records. PLoS One. 2013;10(8):e75214.CrossRef Yoon D, Park I, Schuemie M, Park M, Kim J, Park R. A quantitative method for assessment of prescribing patterns using electronic health records. PLoS One. 2013;10(8):e75214.CrossRef
29.
go back to reference Malo S, Bjerrum L, Feja C, Lallana M, Moliner J, Rabanaque M. Compliance with recommendations on outpatient antibiotic prescribing for respiratory tract infections: the case of Spain. Basic Clin Pharmacol Toxicol. 2014;. doi:10.1111/bcpt.12316. Malo S, Bjerrum L, Feja C, Lallana M, Moliner J, Rabanaque M. Compliance with recommendations on outpatient antibiotic prescribing for respiratory tract infections: the case of Spain. Basic Clin Pharmacol Toxicol. 2014;. doi:10.​1111/​bcpt.​12316.
30.
go back to reference Warlé-van Herwaarden M, Valkhoff V, Teichert M, Koffeman A, ‘t Jong G, Sturkenboom M, et al. Development and application of indicators for the reduction of potentially preventable hospital admissions related to medications. Expert Opin Drug Saf. 2014;13(2):157–65.CrossRefPubMed Warlé-van Herwaarden M, Valkhoff V, Teichert M, Koffeman A, ‘t Jong G, Sturkenboom M, et al. Development and application of indicators for the reduction of potentially preventable hospital admissions related to medications. Expert Opin Drug Saf. 2014;13(2):157–65.CrossRefPubMed
31.
go back to reference Jamtvedt G, Young J, Kristoffersen D, O’Brian M, Oxman A. Does telling people what they have been doing change what they do? A systemati review of the effects of audit and feedback. Qual Saf Health Care. 2006;15:433–6.CrossRefPubMedPubMedCentral Jamtvedt G, Young J, Kristoffersen D, O’Brian M, Oxman A. Does telling people what they have been doing change what they do? A systemati review of the effects of audit and feedback. Qual Saf Health Care. 2006;15:433–6.CrossRefPubMedPubMedCentral
34.
go back to reference Schalekamp T, van Geest-Daalderop J, Kramer M, van Holten-Verzantvoort A, de Boer A. Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction. Eur J Clin Pharmacol. 2007;63(4):335–43.CrossRefPubMedPubMedCentral Schalekamp T, van Geest-Daalderop J, Kramer M, van Holten-Verzantvoort A, de Boer A. Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction. Eur J Clin Pharmacol. 2007;63(4):335–43.CrossRefPubMedPubMedCentral
35.
go back to reference Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, Hiroeh U, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med. 2006;355(4):375–84.CrossRefPubMed Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, Hiroeh U, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med. 2006;355(4):375–84.CrossRefPubMed
Metadata
Title
Quality indicators for pharmaceutical care: a comprehensive set with national scores for Dutch community pharmacies
Authors
Martina Teichert
Tim Schoenmakers
Nico Kylstra
Berend Mosk
Marcel L. Bouvy
Frans van de Vaart
Peter A. G. M. De Smet
Michel Wensing
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0301-x

Other articles of this Issue 4/2016

International Journal of Clinical Pharmacy 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.